Banco Bilbao Vizcaya Argentaria, S.A. Organon & Co. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$31.66 - $38.9 $12,030 - $14,782	380 Added 6.38%	6,340 $214,000
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $101,368 - $131,029	-3,329 Reduced 35.84%	5,960 $209,000
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $1,290 - $1,670	-45 Reduced 0.48%	9,289 $286,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $17,178 - $21,384	-600 Reduced 6.04%	9,334 $306,000
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $282,622 - $377,492	9,934 New	9,934 $301,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.